Related references
Note: Only part of the references are listed.Role of FGFR3 in bladder cancer: Treatment landscape and future challenges
Claudia Maria Ascione et al.
CANCER TREATMENT REVIEWS (2023)
Cancer statistics, 2023
Rebecca L. Siegel et al.
CA-A CANCER JOURNAL FOR CLINICIANS (2023)
Aberrant Expression and Prognostic Potential of IL-37 in Human Lung Adenocarcinoma
Panayiota Christodoulou et al.
BIOMEDICINES (2022)
ARID1A-deficient bladder cancer is dependent on PI3K signaling and sensitive to EZH2 and PI3K inhibitors
Hasibur Rehman et al.
JCI INSIGHT (2022)
Expression of IL-37 Induces a Regulatory T-Cell-like Phenotype and Function in Jurkat Cells
Douglas Grant Osborne et al.
CELLS (2022)
Interleukin-37 promotes colitis-associated carcinogenesis via SIGIRR-mediated cytotoxic T cells dysfunction
Zhen Wang et al.
SIGNAL TRANSDUCTION AND TARGETED THERAPY (2022)
Neutrophil percentage-to-albumin ratio predicts mortality in bladder cancer patients treated with neoadjuvant chemotherapy followed by radical cystectomy
Matteo Ferro et al.
FUTURE SCIENCE OA (2021)
Global cancer statistics 2020: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries
Hyuna Sung et al.
CA-A CANCER JOURNAL FOR CLINICIANS (2021)
TNMplot.com: A Web Tool for the Comparison of Gene Expression in Normal, Tumor and Metastatic Tissues
Aron Bartha et al.
INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES (2021)
Pancancer survival analysis of cancer hallmark genes
Adam Nagy et al.
SCIENTIFIC REPORTS (2021)
IL-37 Was Involved in Progress of Acute Myeloid Leukemia Through Regulating IL-6 Expression
Xiaonan Wei et al.
CANCER MANAGEMENT AND RESEARCH (2021)
Reduced IL-37 gene expression and CD8 T lymphocytes in patients with metastatic breast cancer
Najmeh Farahani et al.
Breast Disease (2021)
Tumor microenvironment of human breast cancer, and feline mammary carcinoma as a potential study model
Catarina Nascimento et al.
BIOCHIMICA ET BIOPHYSICA ACTA-REVIEWS ON CANCER (2021)
Current Understanding of IL-37 in Human Health and Disease
Zhangci Su et al.
FRONTIERS IN IMMUNOLOGY (2021)
Mechanisms of immune evasion in bladder cancer
Paul L. Crispen et al.
CANCER IMMUNOLOGY IMMUNOTHERAPY (2020)
The indirect antiangiogenic effect of IL-37 in the tumor microenvironment
Yu Mei et al.
JOURNAL OF LEUKOCYTE BIOLOGY (2020)
The balance of serum IL-18/IL-37 levels is disrupted during the development of oral squamous cell carcinoma
Liang Ding et al.
SURGICAL ONCOLOGY-OXFORD (2020)
TIMER2.0 for analysis of tumor-infiltrating immune cells
Taiwen Li et al.
NUCLEIC ACIDS RESEARCH (2020)
Interleukin-37 suppresses hepatocellular carcinoma growth through inhibiting M2 polarization of tumor-associated macrophages
Zhihao Zhang et al.
MOLECULAR IMMUNOLOGY (2020)
Bladder cancer, a unique model to understand cancer immunity and develop immunotherapy approaches
Dongkui Song et al.
JOURNAL OF PATHOLOGY (2019)
Interleukin-37 is highly expressed in regulatory T cells of melanoma patients and enhanced by melanoma cell secretome
Douglas G. Osborne et al.
MOLECULAR CARCINOGENESIS (2019)
IL-37 induces anti-tumor immunity by indirectly promoting dendritic cell recruitment and activation in hepatocellular carcinoma
Yuan Liu et al.
CANCER MANAGEMENT AND RESEARCH (2019)
The multifaceted immune regulation of bladder cancer
Anna K. Schneider et al.
NATURE REVIEWS UROLOGY (2019)
New Clinical Approaches and Emerging Evidence on Immune-Checkpoint Inhibitors as Anti-Cancer Therapeutics: CTLA-4 and PD-1 Pathways and Beyond
Maria-Ioanna Christodoulou et al.
CRITICAL REVIEWS IN IMMUNOLOGY (2019)
Suppression of inflammation and acquired immunity by IL-37
Giulio Cavalli et al.
IMMUNOLOGICAL REVIEWS (2018)
Intracellular mature IL-37 suppresses tumor metastasis via inhibiting Rac1 activation
Y. Li et al.
ONCOGENE (2018)
Conventional and PD-L1-expressing Regulatory T Cells are Enriched During BCG Therapy and may Limit its Efficacy
Mathieu F. Chevalier et al.
EUROPEAN UROLOGY (2018)
Exponential scaling of single-cell RNA-seq in the past decade
Valentine Svensson et al.
NATURE PROTOCOLS (2018)
ARID1A loss in cancer: Towards a mechanistic understanding
Radhika Mathur
PHARMACOLOGY & THERAPEUTICS (2018)
IL-37 isoform D downregulates pro-inflammatory cytokines expression in a Smad3-dependent manner
Mingsheng Zhao et al.
CELL DEATH & DISEASE (2018)
Mutations of p53 decrease sensitivity to the anthracycline treatments in bladder cancer cells
Sony Pandey et al.
Oncotarget (2018)
Prognostic significance of nomograms integrating IL-37 expression, neutrophil level, and MMR status in patients with colorectal cancer
Bing Zhu et al.
CANCER MEDICINE (2018)
Monocytes and dendritic cells are the primary sources of interleukin 37 in human immune cells
Ina Rudloff et al.
JOURNAL OF LEUKOCYTE BIOLOGY (2017)
Comprehensive Molecular Characterization of Urothelial Bladder Carcinoma: A Step Closer to Clinical Translation?
Cyrill A. Rentsch et al.
EUROPEAN UROLOGY (2017)
Bladder Cancer Incidence and Mortality: A Global Overview and Recent Trends
Sebastien Antoni et al.
EUROPEAN UROLOGY (2017)
EAU Guidelines on Non-Muscle-invasive Urothelial Carcinoma of the Bladder: Update 2016
Marko Babjuk et al.
EUROPEAN UROLOGY (2017)
Regulatory T Cells and Tumor-Associated Macrophages in the Tumor Microenvironment in Non-Muscle Invasive Bladder Cancer Treated with Intravesical Bacille Calmette-Guerin: A Long-Term Follow-Up Study of a Japanese Cohort
Makito Miyake et al.
INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES (2017)
Interleukin 37 reverses the metabolic cost of inflammation, increases oxidative respiration, and improves exercise tolerance
Giulio Cavalli et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2017)
Treating experimental arthritis with the innate immune inhibitor interleukin-37 reduces joint and systemic inflammation (vol 55, pg 2220, 2016)
Giulio Cavalli et al.
RHEUMATOLOGY (2017)
UALCAN: A Portal for Facilitating Tumor Subgroup Gene Expression and Survival Analyses
Darshan S. Chandrashekar et al.
NEOPLASIA (2017)
Bladder cancer
Oner Sanli et al.
NATURE REVIEWS DISEASE PRIMERS (2017)
The Many Roles of BAF (mSWI/SNF) and PBAF Complexes in Cancer
Courtney Hodges et al.
COLD SPRING HARBOR PERSPECTIVES IN MEDICINE (2016)
The ratio of CD8 to Treg tumor-infiltrating lymphocytes is associated with response to cisplatin-based neoadjuvant chemotherapy in patients with muscle invasive urothelial carcinoma of the bladder
Alexander S. Baras et al.
ONCOIMMUNOLOGY (2016)
IL-37 requires the receptors IL-18Rα and IL-1R8 (SIGIRR) to carry out its multifaceted anti-inflammatory program upon innate signal transduction
Claudia A. Nold-Petry et al.
NATURE IMMUNOLOGY (2015)
Biophysical Characterization of Bladder Cancer Cells with Different Metastatic Potential
Haijiao Liu et al.
CELL BIOCHEMISTRY AND BIOPHYSICS (2014)
Long-range DNA interactions at the IL-1/IL-36/IL-37 gene cluster (2q13) are induced by activation of monocytes
Nazar Sharaf et al.
CYTOKINE (2014)
Comprehensive molecular characterization of urothelial bladder carcinoma
John N. Weinstein et al.
NATURE (2014)
Role of caspase-1 in nuclear translocation of IL-37, release of the cytokine, and IL-37 inhibition of innate immune responses
Ana-Maria Bulau et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2014)
Loss of nuclear prothymosin-α expression is associated with disease progression in human superficial bladder cancer
Yuh-Shyan Tsai et al.
VIRCHOWS ARCHIV (2014)
Whole-genome sequencing of bladder cancers reveals somatic CDKN1A mutations and clinicopathological associations with mutation burden
J. -B. Cazier et al.
NATURE COMMUNICATIONS (2014)
IL-37 Inhibits Inflammasome Activation and Disease Severity in Murine Aspergillosis
Silvia Moretti et al.
PLOS PATHOGENS (2014)
Genomics of Drug Sensitivity in Cancer (GDSC): a resource for therapeutic biomarker discovery in cancer cells
Wanjuan Yang et al.
NUCLEIC ACIDS RESEARCH (2013)
Urothelial carcinoma of the bladder: definition, treatment and future efforts
Sandip M. Prasad et al.
NATURE REVIEWS UROLOGY (2011)
Characteristics of the minor salivary gland infiltrates in Sjogren's syndrome
Maria I. Christodoulou et al.
JOURNAL OF AUTOIMMUNITY (2010)
IL-37 is a fundamental inhibitor of innate immunity
Marcel F. Nold et al.
NATURE IMMUNOLOGY (2010)
The IL-1 family: regulators of immunity
John E. Sims et al.
NATURE REVIEWS IMMUNOLOGY (2010)
Blinded by the Light: The Growing Complexity of p53
Karen H. Vousden et al.
CELL (2009)
Recurrence and Progression of Disease in Non-Muscle-Invasive Bladder Cancer: From Epidemiology to Treatment Strategy
Bas W. G. van Rhijn et al.
EUROPEAN UROLOGY (2009)
Foxp3+ T-Regulatory Cells in Sjogren's Syndrome Correlation with the Grade of the Autoimmune Lesion and Certain Adverse Prognostic Factors
Maria I. Christodoulou et al.
AMERICAN JOURNAL OF PATHOLOGY (2008)
The IL-1 family member 7b translocates to the nucleus and down-regulates proinflammatory cytokines
Sheetal Sharma et al.
JOURNAL OF IMMUNOLOGY (2008)
Human bladder carcinoma is dominated by T-regulatory cells and Th1 inhibitory cytokines
Angelica Loskog et al.
JOURNAL OF UROLOGY (2007)
Molecular profiling of bladder tumors based on the detection of FGFR3 and TP53 mutations
A. Lamy et al.
JOURNAL OF UROLOGY (2006)
Gain of function of a p53 hot spot mutation in a mouse model of Li-Fraumeni syndrome
GA Lang et al.
CELL (2004)
Interleukin-1 homologues lL-1F7b and IL-18 contain functional mRNA instability elements within the coding region responsive to lipopolysaccharide
P Bufler et al.
BIOCHEMICAL JOURNAL (2004)
Proteomics-based identification of proteins interacting with Smad3: SREBP-2 forms a complex with Smad3 and inhibits its transcriptional activity
S Grimsby et al.
FEBS LETTERS (2004)
SIGIRR, a negative regulator of Toll-like receptor-interleukin 1 receptor signaling
D Wald et al.
NATURE IMMUNOLOGY (2003)
Analysis of relative gene expression data using real-time quantitative PCR and the 2-ΔΔCT method
KJ Livak et al.
METHODS (2001)
Share Paper
